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In mice and humans, binding of a-melanocyte–stimulating hormone to the melanocyte-stimulating–hormone re-
ceptor (MSHR), the protein product of melanocortin-1 receptor (MC1R) gene, leads to the synthesis of eumelanin.
In the mouse, ligation of MSHR by agouti signaling protein (ASP) results in the production of pheomelanin. The
role of ASP in humans is unclear. We sought to characterize the agouti signaling protein gene (ASIP) in a group
of white subjects, to assess whether ASIP was a determinant of human pigmentation and whether this gene may
be associated with increased melanoma risk. We found no evidence of coding-region sequence variation in ASIP,
but detected a g.8818ArG polymorphism in the 3′ untranslated region. We genotyped 746 participants in a study
of melanoma susceptibility for g.8818ArG, by means of polymerase chain reaction and restriction fragment–length
polymorphism analysis. Among the 147 healthy controls, the frequency of the G allele was .12. Carriage of the G
allele was significantly associated with dark hair (odds ratio 1.8; 95% confidence interval [CI] 1.2–2.8) and brown
eyes (odds ratio 1.9; 95% CI 1.3–2.8) after adjusting for age, gender, and disease status. ASIP g.8818ArG was
not associated independently with disease status. This is the first report of an association of ASIP with specific
human pigmentation characteristics. It remains to be investigated whether the interaction of MC1R and ASIP can
enhance prediction of human pigmentation and melanoma risk.
The genetic control of human pigmentation is complex
and not well understood. Melanogenesis is regulated, in
part, by the binding of a-melanocyte–stimulating hor-
mone (a-MSH) to the melanocyte-stimulating–hormone
receptor (MSHR [MIM 155555]; Suzuki et al. 1996).
This action initiates a signal cascade acting through ad-
enylate cyclase that leads to increased intracellular levels
of cyclic adenosine monophosphate (cAMP), increased
expression of tyrosinase, and, ultimately, the production
of eumelanin (Hunt et al. 1994). Recent investigations
published in this journal have demonstrated that the
melanocortin-1 receptor (MC1R) gene, which codes for
MSHR, is highly polymorphic (Harding et al. 2000) and
is associated with pigmentation characteristics (Palmer
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et al. 2000; Bastiaens et al. 2001), risk of melanoma
(Palmer et al. 2000), and risk of nonmelanoma skin can-
cers (Bastiaens et al. 2001). MC1R can also act as a
modifier of melanoma risk within melanoma-prone fam-
ilies (Box et al. 2001; van Der Velden et al. 2001).
In the mouse, melanogenesis is also regulated, in part,
by agouti signaling protein (ASP [MIM 600201]. The
binding of ASP to MSHR precludes a-MSH–initiated
signaling and thus blocks production of cAMP, leading
to a downregulation of eumelanogenesis (Lu et al. 1994;
Suzuki et al. 1997; Yang et al. 1997). The net result is
increased synthesis of pheomelanin. The human agouti
signaling protein gene (ASIP; GenBank accession num-
ber AL035458) encodes a 132–amino acid protein that
is highly similar to mouse ASIP, both at the transcrip-
tional and translational levels (Kwon et al. 1994; Wilson
et al. 1995). Initial experiments showed that human
ASIP expression in transgenic mice gives rise to yellow
coat colors and decreased cAMP levels in vitro (Wilson
et al. 1995).
We sought to characterize genetic variants in ASIP in
a sample of healthy white subjects from the mid-Atlantic
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Table 1
Cycling and Reagent Conditions for ASIP Amplification and Sequencing
Exon Primers and PCR Products Reagents Cycling Parameters
2 For PCR: forward 5′-GTCCCACT-
CAGGCCTCCT-3′, reverse 5′-G-
AGCCCAGAGGCTAGGTGA-
3′, 205-bp product; for
sequencing: 5′-GTCCCACTCA-
GGCCTCCT-3′ and 5′-GAGCC-
CAGAGGCTAGGTGA-3′
10 ml DNA template; .5 mM forward and reverse
primers; 200 mM each dATP, dCTP, dGTP, dTTP;
1.5 mM MgCl2, 1.5 ml 1 M tetramethylammonium
chloride (TMAC); 5 ml 10# Buffer (PE Applied
Biosystems); .5 ml AmpliTaq DNA polymerase (PE
Applied Biosystems); ddH20 to 50 ml
Robocycler 96 (Stratagene); 1
cycle of 5 min at 95C; 35 cy-
cles of 1 min at 94C, 1 min
at 57C, and 1.5 min at 68C;
and 1 cycle of 10 min at 72C
3 For PCR: forward 5′-CGCTTCTT-
CTCCTCTC-3′, reverse 5′-CTTC-
CCTGCCCTTAC-3′, 195-bp
product; for sequencing: 5′-CGC-
TTCTTCTCCTCTC-3′
10 ml DNA template; .5 mM forward and reverse
primer; 200 mM each dATP, dCTP, dGTP, dTTP;
1.5 mM MgCl2, 1.5 ml 1M TMAC; 5 ml 10# buf-
fer; .5 ml AmpliTaq DNA polymerase, ddH20 to 50
ml
Robocycler 96; 1 cycle of 5 min
at 95C; 35 cycles of 1 min at
94C, 1 min at 57C, and 1.5
min at 68C; and 1 cycle of
10 min at 72C
4 For PCR: forward 5′-TGGAGGTG-
AGGGAATCTGAC-3′, reverse
5′-ACTGGGAGTGCAGCTGT-
GA-3′, 648-bp product; for se-
quencing: 5′-TCTGGTCCGGG-
ATCTCCCTAG-3′
6 ml DNA template; .4 mM forward and reverse
primer; .4 ml 50# dNTP mixa; .88 ml 25mM
Mg(OAc)2
a, 4 ml GC-Melta; 4 ml 5# GC PCR buf-
fera; .4 ml Advantage-GC polymerase mixa; ddH20
to 25 ml
Robocycler 96; 1 cycle of 5 min
at 95C; 40 cycles of 1 min at
94C, 1 min at 57C, and 1
min at 72C; 1 cycle of 10
min at 72C
3′ UTR For PCR: forward 5′-GTGCTCAG-
CCTCAACTGCT-3′, reverse 5′-
CACACCTTCGAGCAGCCTA-
T-3′, 208-bp product
10 ml DNA template; .5 mM forward and reverse
primer; 200 mM each dATP, dCTP, dGTP, dTTP; 2
mM MgCl2; 5 ml dimethyl sulfoxide; 1.5 ml bovine
serum albumin; 5 ml 10# buffer; 1.2 ml AmpliTaq
DNA polymerase; ddH20 to 50 ml
Robocycler 96; 1 cycle of 5 min
at 95C; 35 cycles of 30 s at
94C, 30 s at 55C, and 30 s
at 72C; and 1 cycle of 7 min
at 72C
a Advantage-GC Genomic PCR kit (Clontech).
region of the United States. We also determined whether
sequence variants in ASIP were associated with pig-
mentation characteristics and an elevated risk of mela-
noma or dysplastic nevi (DN), which are atypical moles
that are epidemiological risk markers of melanoma and
nonobligate precursors (Tucker et al. 1997).
Our study population consisted of participants en-
rolled in a previously described molecular epidemiolog-
ical investigation of melanoma susceptibility and in-
cluded 147 healthy control subjects, 176 persons with
DN, and 423 patients with melanoma with or without
a diagnosis of DN (Kanetsky et al. 2001). The University
of Pennsylvania’s institutional review board that over-
sees research involving human beings approved the study
protocol. In brief, patients with a histologically con-
firmed diagnosis of incident melanoma or a clinical di-
agnosis of DN were eligible to participate. These patients
were each asked to refer a healthy non–blood relative
or friend to be control subjects. Each participant signed
informed consent, completed a questionnaire eliciting
information on pigmentation characteristics, gave buc-
cal-swab samples containing genomic DNA, and un-
derwent a skin examination to enumerate and charac-
terize nevi, eye color, and freckling.
To describe human ASIP, we use nomenclature
adopted from mouse ASIP, which consists of a noncoded
first exon, followed by three coding exons, designated
2, 3, and 4 (reviewed by Siracusa [1994]). We completely
characterized the coding regions of ASIP exons 2 (g.1-
160), 3 (g.2458-2519), and 4 (g.8617-8793), including
a portion of the 3′ UTR of exon 4 (g.8794–8968). ASIP
gene regions were PCR-amplified and were sequenced
directly on an ABI Prism 377 (Applied Biosystems) using
Big Dye Terminators (Applied Biosystems) according to
the manufacturer’s specifications. Table 1 lists the prim-
ers, reagents, and reaction conditions used for PCR am-
plification and sequencing of ASIP.
We developed a PCR-RFLP assay to genotype the
ASIP g.8818ArG polymorphism. The PCR conditions
are given in table 1. Presence of the G allele gave rise
to a unique BsrBI cleavage site within the expected 208-
bp amplicon, resulting in products 161 bp and 47 bp in
size. As an internal control that indicated incomplete or
failed digestion, we added a known MC1R PCR product
that contained a single, nonpolymorphic BsrBI recog-
nition site that produced fragments 766 and 359 bp in
size, after appropriate digestion. We digested 10 ml of
ASIP PCR template and 2 ml of control MC1R PCR
template with 3 ml of BsrBI (New England Biolabs), 2.5
ml of BsrBI buffer, and 7.5 ml of ddH20 for at least 4 h
at 55C. Genotyping was completed by visualization of
banding patterns on a 3% agarose gel after ethidium
bromide staining.
Statistical analyses were undertaken using SAS for
Windows v8.01 (SAS Institute). x2 analysis was used to
test for differences in disease status and pigmentation
characteristics, as well as disease status and ASIP ge-
notype. We used logistic regression to estimate the odds
ratio (OR) and 95% CI for associations of ASIP ge-
notype (G/ vs. A/A) and pigmentation characteristics
after adjustment for age, sex, and disease status. Logistic
regression models containing indicator variables were
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Table 2
ASIP g.8818ArG Genotype and Allele Frequency by
Disease Status
GENOTYPE
NO. (%) OF SUBJECTSa
Control
( )bnp 147
with DN
( )cnp 176
with Melanoma
( )dnp 423
A/A 114 (78) 132 (75) 330 (78)
A/G 30 (20) 44 (25) 87 (21)
G/G 3 (2) 0 (0) 6 (1)
a .Pp .34
b Frequency of G allele p .12.
c Frequency of G allele p .13.
d Frequency of G allele p .12.
used to assess associations of heterozygous (A/G vs. A/
A) and homozygous (G/G vs. A/A) carriage and pig-
mentation characteristics.
From a convenient sample of 105 healthy control sub-
jects, we successfully completed PCR amplification and
directly sequenced 92 samples for ASIP exon 2, 97 sam-
ples for ASIP exon 3, and 55 samples for ASIP exon 4,
including the 3′ UTR. Overall, samples from 52 indi-
viduals (104 chromosomes) were completely sequenced
for all three ASIP regions. We did not detect a sequence
variant in the ASIP coding regions. However, we de-
tected a polymorphism in the 3′ UTR of ASIP, defined
by the presence of an A or G at a position 25 bp down-
stream of the TGA termination codon in the noncoding
exon 4. On the basis of the genomic DNA sequence
available for ASIP, we designated this polymorphism as
g.8818ArG (Beaudet and Tsui 1993; Antonarakis
1998). Among the 147 healthy control subjects geno-
typed for the polymorphism, the G allele occurred at a
frequency of .12 and was in Hardy-Weinberg propor-
tions (df 1; ; ). Table 2 contains results2x p .18 Pp .67
from ASIP g.8818ArG genotyping among the healthy
control, DN, and melanoma groups. ASIP genotypes
were similar across the groups.
Pigmentation characteristics for the total study pop-
ulation are given in table 3. As expected, there were
significant differences among the healthy control, DN,
and melanoma groups for most characteristics, including
hair color, eye color, freckling, and total number of com-
mon acquired nevi. Differences between the groups in
skin reaction to first intense and repeated sun exposure
approached but did not reach significance. Table 4 pre-
sents results from crude and adjusted analyses estimating
the association between specific pigmentation charac-
teristics and carriage of the ASIP variant. These data
indicate that carriage of the G allele was significantly
associated with having dark hair (OR 1.8; 95% CI
1.2–2.8) and brown eyes (OR 1.9; 95% CI 1.3–2.7) after
adjustment for age, sex, and disease status. The asso-
ciations with dark hair and brown eyes remained sig-
nificant even after additional adjustment for the re-
maining pigmentation characteristics in the table (dark
hair: OR 1.7 and 95% CI 1.1–2.8; brown eyes: OR 1.6
and 95% CI 1.1–2.4). Although only nine samples were
genotyped as G/G, results from logistics models provide
some indication that there may be an ASIP allele-dosage
effect such that homozygous carriers may have an in-
creased likelihood of having dark hair and brown eyes
compared with heterozygous carriers (see table 4). We
also reran logistic models among the subset of 679 sub-
jects who had complete information on all pigmentation
variables. Results were nearly identical for ASIP asso-
ciations with hair and eye color.
Although we statistically adjusted for DN and mela-
noma status in the above analyses, we further explored
the possibility that the observed association between
ASIP genotype and pigmentation could have been me-
diated, in part, by disease status. Our data do not suggest
that the ASIP g.8818ArG polymorphism is associated
with an alteration in susceptibility to melanoma. We did
not note any difference in the proportion of carriers
when subjects with melanoma were compared with con-
trol subjects (OR .97; 95% CI .62–1.5) or with subjects
with DN (OR .85; 95% CI .56–1.3). As well, no dif-
ference was noted when subjects with DN were com-
pared to control subjects (OR 1.2; 95% CI .69–1.9).
Hardy-Weinberg proportions were evident among pa-
tients with melanoma (df 1; ; ) and2x p .025 Pp .88
the total study sample (df 1; ; ). How-2x p .53 Pp .47
ever, among subjects with DN, we noted a slight devi-
ation from Hardy-Weinberg proportions (df 1; 2x p
; ), caused by a deficiency of homozygous4.6 Pp .033
G/G carriers. In post hoc analyses, the addition of one
homozygous variant carrier or reassignment of one het-
erozygous carrier to homozygous status would have re-
sulted in Hardy-Weinberg proportions in the DN group
(df 1; ; and df 1; ; ,2 2x p 2.4 Pp .12 x p 2.3 Pp .13
respectively).
This is the first study to show that an ASIP poly-
morphism may play a role in human pigmentation char-
acteristics, specifically hair and eye color. Two previous
reports have investigated ASIP sequence variation. In
1999, Norman et al. genotyped 24 samples collected
from Pima Indians (Norman et al. 1999); coding-region
variants were not detected, nor did they characterize
noncoding regions of ASIP. A recent publication (Voisey
et al. 2001) reported screening for ASIP polymorphisms
in coding and noncoding regions, including noncoding
exon 1, in several small sample sets derived from dif-
ferent populations, including white, African American,
Spanish Basque, Hispanic, Apache, and Australian Ab-
original ones. Although coding-region variation was not
found, Voisey et al. (2001) detected the g.8818ArG
polymorphism in 3 of 10 African American, 1 of 4 Asian,
and 1 of 34 white samples. We calculated the polymor-
phism frequency among whites in the report by Voisey
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Table 3
Frequency of Pigmentation Characteristics by Disease Status
PIGMENTATION CHARACTERISTICa
NO. (%) OF SUBJECTS
Control
( )np 147
with DN
( )np 176
with Melanoma
( )np 423
Hair color:b
Red or reddish brown 9 (6) 5 (3) 53 (13)
Blond 26 (18) 34 (20) 85 (20)
Dark 111 (76) 133 (77) 277 (67)
Eye color:c
Blue or gray 49 (37) 55 (34) 184 (45)
Green or hazel 26 (20) 46 (29) 114 (28)
Light or dark brown 58 (44) 60 (37) 111 (27)
Skin reaction to first intense sun exposure:d
Burn with blistering 13 (9) 13 (8) 57 (14)
Burn without blistering 48 (33) 74 (43) 156 (38)
Mild burn then tan or no burn 84 (58) 84 (49) 201 (49)
Skin reaction to repeated sun exposure:d
No tan 6 (4) 7 (4) 30 (7)
Light tan 32 (22) 43 (25) 126 (31)
Medium or dark tan 106 (74) 120 (71) 254 (62)
Freckling:e
Extensive 56 (42) 70 (43) 258 (62)
Moderate 29 (22) 40 (25) 95 (23)
Mild 32 (24) 44 (27) 49 (12)
Absent 16 (12) 8 (5) 11 (3)
No. of common acquired nevi:e
75 1 (1) 90 (56) 82 (20)
50–74 6 (5) 19 (12) 40 (10)
25–49 12 (9) 28 (17) 75 (18)
24 114 (86) 25 (15) 216 (52)
a Data were missing on hair color for 13 persons, on eye color for 43 persons, on skin
reaction to first intense sun exposure for 16 persons, on skin reaction to repeated sun
exposure for 22 persons, and on freckling and number of common acquired nevi for 38
persons.
b for these values.Pp .0014
c for these values.Pp .0022
d for these values.Pp .059
e for these values.P  .0001
et al. (2001) to be .015, nearly 10-fold lower than that
reported here. This discrepancy in allele frequency is
likely due to the white population selected for genotyp-
ing by Voisey et al. (2001), of whom half had either red
or blond hair color. However, this finding is consistent
with the predicted direction of effect for the g.8818ArG
variant that would be expected to be underrepresented
in individuals with low-eumelanin pigmentation types.
Although novel within the field of human pigmenta-
tion, our results parallel those of two investigations that
molecularly characterized recessive mutations in ASIP
that are associated with varied patterns of darkened coat
colors seen in several mouse strains (Bultman et al. 1994;
Hustad et al. 1995). Two pigmentation patterns arose
from insertion mutations in ASIP intron 1 (Bultman et
al. 1994)—one pattern from a point mutation and one
from a base-pair deletion in ASIP coding regions—and
four other patterns arose from mutations in the ASIP
regulatory region (Hustad et al. 1995). These data indi-
cate that decreased ASIP function may result from genetic
alterations in nearly all gene domains of ASIP. Impor-
tantly, the 3′ UTR domains of primary transcripts have
been shown to be critical to mRNA stability (reviewed
by Ross [1995]). If the G allele destabilizes ASIP mRNA,
leading to the premature degradation of transcript, it is
possible that decreased levels of ASIP could preclude the
blocking of a-MSH–mediated signaling, leading ulti-
mately to a bias toward eumelanin synthesis and away
from production of pheomelanin. Investigation of the
functional significance of this polymorphism and of
whether the G allele effects mRNA stability is necessary
to corroborate our findings at a mechanistic level. In ad-
dition, it remains possible that sequence variation in other
noncoding domains of ASIP (e.g., the promoter or in-
tronic regions) may be associated with human pigmen-
tation or disease risk. Although Voisey et al. did not find
evidence of variants inASIP noncoding exon 1, the search
for polymorphic sites in other noncoding regions should
be targeted for future investigation.
In mouse, an effect of ASIP was not observed against
the genetic background of a nonfunctional MSHR (Oll-
mann et al. 1998; Abdel-Malek et al. 2001). Further-
more, against a genetic background of limited tyrosinase
production (Tyrch/Tyrch), mouse strains that expressed
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Table 4
Association of Pigmentation Characteristics for ASIP 8818G Allele Carriers
PIGMENTATION CHARACTERISTIC
CARRIER HETEROZYGOTE HOMOZYGOTE
G/ vs. A/A G/ vs. A/A A/G vs. A/A G/G vs. A/A
OR 95% CI ORa 95% CI ORa 95% CI ORa 95% CI
Hair color:
Red, reddish brown, or blond 1.0 1.0 1.0 1.0
Dark 1.9 1.2–2.8 1.8 1.2–2.8 1.8 1.2–2.7 3.3 .40–27
Eye color:
Blue, gray, green, or hazel 1.0 1.0 1.0 1.0
Light or dark brown 1.9 1.3–2.7 1.9 1.3–2.8 1.9 1.3–2.7 3.4 .74–16
Skin reaction to first intense sun exposure:
Burn with or without blistering 1.0 1.0
Mild burn then tan or no burn 1.2 .86–1.7 1.2 .81–1.6
Skin reaction to repeated sun exposure:
No or light tan 1.0 1.0
Medium or dark tan 1.5 1.0–2.3 1.4 .96–2.1
Freckling:
Extensive or moderate 1.0 1.0
Mild or none 1.1 .70–1.6 .99 .64–1.5
No. of common acquired nevi:
25 1.0 1.0
24 1.2 .87–1.8 1.2 .87–1.8
a Adjusted for age, sex, and disease status.
both ASIP (Ay/a) and a functional MC1R produced a
lighter-colored coat than those strains expressing a non-
functional MC1R (Mc1re/Mc1re), regardless of ASIP ex-
pression (Ollmann et al. 1998). Taken together, these
results indicate that ASIP may affect melanogenesis to a
greater degree than lack of MSH signaling alone.
Human MC1R is highly polymorphic, and sequence
variants have been associated with several cutaneous pig-
mentary phenotypes and with elevated risks of skin ne-
oplasms (Valverde et al. 1995; Palmer et al. 2000; Bas-
tiaens et al. 2001). Most MC1R variants are point
mutations, some of which have been shown to compro-
mise the quantity of a-MSH–induced cAMP production
(Schioth et al. 1999). In one investigation, the Arg151Cys
variant resulted in MC1R loss of function (Frandberg et
al. 1998). Arg151Cys is one of several MC1R variants
that, alone or in combination, have been strongly asso-
ciated with red hair color (Valverde et al. 1995; Box et
al. 1997; Palmer et al. 2000; Bastiaens et al. 2001). We
can speculate that, analogous to mouse models, against
a genetic background devoid of MC1R function, there
could be limited or no effect of g.8818ArG; however,
against a background of decreased MC1R function, it is
plausible that ASIP could effect melanogenesis. Thus,
ASIP genotyping may help explain those instances where
MC1R genotyping predicts red hair although the subject
has brown hair.
The addition of ASIP g.8818ArG genotyping to stud-
ies exploring human pigmentation may prove to be of
interest and utility. Because ASIP and MC1R interact at
the level of ligand and receptor, it is possible that the
combination of ASIP and MC1R may associate better
with pigmentation, such as hair and eye color, than either
gene does alone. Even though, in our data, ASIP did not
demonstrate a direct association with melanoma, it re-
mains biologically plausible that interactive effects of
ASIP may exist in combination with MC1R variants or
one of the many other genes involved in pigmentation
pathways. Hence, ASIP g.8818ArG genotyping may be
meaningful in further investigations of melanoma and
nonmelanoma skin neoplasms and may contribute in-
dependent information in the construction of future mul-
tivariable risk models of melanoma.
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